Meeting
2022 ASCO Annual Meeting
At-risk patient and healthcare provider perspectives on clinical trial participation for ductal carcinoma in situ.
Authors
Elizabeth Adams
Northwestern University Feinberg School of Medicine, Chicago, IL
Elizabeth Adams , Swati Kulkarni , Veronica Zheng , Samantha Ahsan Warwar , Denisha Brown , Lauren Schulte , Robin Cooper , Bazil Labomascus , Erica B. Bhavsar
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Prevention, Risk Reduction, and Hereditary Cancer
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Cancer Prevention
Clinical Trial Registration Number
NCT02694809
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 10539)
DOI
10.1200/JCO.2022.40.16_suppl.10539
Abstract #
10539
Poster Bd #
415
Abstract Disclosures
Similar Posters
Poster
2021 Genitourinary Cancers Symposium
Delaying surgery for clinical T1b-T2bN0M0 renal cell carcinoma: Oncologic implications in the COVID-19 era and beyond.
First Author: Arnav Srivastava
Poster
2023 ASCO Quality Care Symposium
Evaluation of delays to multidisciplinary treatment of soft tissue sarcomas at a tertiary cancer center.
First Author: Kelsey B. Montgomery
Poster
2023 ASCO Quality Care Symposium
Is financial toxicity associated with delays in diagnosis in gynecologic cancers?
First Author: Maria Fatima Reyes
Poster
2023 ASCO Breakthrough
Clinical profiles and outcomes of patients enrolled in the Department of Health: Breast Cancer Medicines Access Program in the Philippines—A single center experience.
First Author: Jason King Dalusung Talao